OVERVIEW

Improving Age-Related Macular Degeneration Outcomes Through Patient and Provider Collaboration is organized by Prime Education, LLC.

Release Date: January 31, 2020
Expire Date: January 31, 2021

Accreditation:
Interprofessional Teams:
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement:
PRIME® designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement:
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement:
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0.31 hour of pharmacology).

Nurse Accreditation Statement:
PRIME® designates this activity for 1.0 contact hour.

Optometric Practitioner Accreditation Statement:
This course has been accredited for 1.0 hour of Continuing Education credit by COPE.

Overview:
There are multiple barriers preventing many patients with age-related macular degeneration (AMD) from initiating and continuing treatment that can improve visual outcomes or prevent vision loss. In this unique podcast, retina specialists share practical insights and results from surveys completed by patients and providers who participated in a national series of collaborative learning sessions.

Learn more about:
• Real-world insights into patient and provider perceptions of AMD
• Patient and provider perspectives on treatment with intravitreal anti-VEGF therapies
• Practical tools and advice for engaging patients with AMD and caregivers in decisions regarding their treatment plans

Learning Objectives:
• Assess gaps in patient-provider knowledge and perceptions about symptoms, risks, treatment, and self-management for AMD
• Implement leading principles, tools, and processes for engaging patients and caregivers in shared decision-making about AMD treatment and management to improve visual outcomes and adherence
• Foster collaborative discussions between patients and retina specialists on recent evidence and guidelines to personalize treatment decision-making for patients with AMD based on individual patient characteristics